Skip to content
Health Care


Specter of MRI Disease Haunts General Electric

General Electric is in a liability fight over a rare disease that has been linked to dyes used in MRIs. Nearly all cases of the disease, nephrogenic systemic fibrosis, have involved people with kidney problems who used the dyes, but GE says there is no proof that its product, Omniscan, causes the crippling illness.

GE Failed to Adequately Warn about Dangers of its MRI Dye, Jury Finds

'Burn the Data': Did a Company Try to Hide Risks of MRI Dye Omniscan?

Late Settlement Averts First Jury Test For Allegations Against General Electric’s Omniscan

General Electric Faces First Jury Test in Omniscan Litigation

FDA Acts to Restrict GE’s Omniscan MRI Drug, and Two Others

Omniscan: The Story So Far

GE Violated Danish Drug Reporting Law in Omniscan Case

Judge Opens Door to Case Against General Electric’s Omniscan

GE’s Own Safety Team Urged Company to Restrict MRI Drug

GE and Muzzled Radiologist End UK Libel Case

Paulson Book: Behind the Scenes, GE’s Top Exec Confided Credit Woes

GE Suit Hushes Scientist Critical of Omniscan

FDA Advised to Tighten Restrictions on GE and Covidien MRI Drugs

Feds May Tighten Rules on Omniscan, a GE MRI Drug

FDA to Take a Second Look at Warnings on MRI Drugs

Specter of MRI Disease Haunts GE